US$ 24.16
insulin drugs glp 1 receptor agaonist market Glucagon-Like Peptide (GLP-1) Agonist Size & Share 2032 GLP-1 Receptor Agonists Obesity Drugs
Description
GLP-1 meds stimulate insulin production when blood sugar is high, stop the liver from releasing excess sugar and slow stomach emptying to prevent blood sugar spikes after meals

The potentially modifiable risk factor in idiopathic intracranial hypertension: Body weight

10.1038/s41598-017-19055-6 48

Recombinant human GLP-1(rhGLP-1) alleviating renal tubulointestitial injury in diabetic STZ-induced rats
